MarketWatch.com - Top Stories

He spotted weight-loss drugs and AI before they became hot. Here’s this investor’s next big idea.

James van Geelen, founder of Citrini Research, is focused on the next stage of AI, surrounding humanoid robots.

Jun 4, 2025 - 11:58
 0
He spotted weight-loss drugs and AI before they became hot. Here’s this investor’s next big idea.
James van Geelen, founder of Citrini Research, is focused on the next stage of AI, surrounding humanoid robots.
Read More

Tags:

Previous Article

Doubled US metals tariffs kick in as deadline for 'best offers' arrives

Next Article

Better Dividend ETF to Buy Now: Schwab U.S. Dividend Equity ETF or Vanguard Divi...

Related Posts

Economy shrank 0.2% in the first quarter, updated GDP shows, as trade wars sapped U.S. growth

Economy shrank 0.2% in the first quarter, updated GDP s...

May 29, 2025  0

What on earth is going on with the American consumer?

What on earth is going on with the American consumer?

Jun 2, 2025  0

Tesla has lost more than $150 billion in market cap since Elon Musk left ‘DOGE.’ Here’s what may be ahead for the stock.

Tesla has lost more than $150 billion in market cap sin...

Jun 5, 2025  0